3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Lymphoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Colonic Neoplasms
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Vasculitis
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Smoking Cessation
1
Recurrence
1
Pancreatic Neoplasms
1
Osteomyelitis
1
Nose Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Metastatic Solid Tumors
1
Lymphoproliferative Disorders
1
Interventions
fluciclovine F-18
2
Positron-Emission Tomography
2
Injections
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
pembrolizumab
1
ioflupane
1
idelalisib
1
aflibercept
1
Water
1
Vertical Dimension
1
Methylene Blue
1
Mammography
1
Drug Delivery Systems
1
Diagnosis, Computer-Assisted
1
Daunorubicin
1
Cytarabine
1
Control Groups
1
CPX-351
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Disease
×
Tomography, X-Ray Computed
×
Clear all
No trials found.